Stallergenes Greer, a leading global healthcare company specialising in allergen immunotherapy (AIT), will be hosting a company-sponsored symposium entitled...
Benzinga 2023-06-09 06:00:00 • 1 min
IgGenix, Inc., a preclinical antibody discovery and development company taking a revolutionary approach to directly address allergic disease, today announced...
Benzinga 2023-06-09 06:00:00 • 2 mins
Long COVIDlike so many invisible illnessesis far more impactful than many healthy individuals realize. A new study out of the U.K. reveals the extreme extent...
Fortune 2023-06-09 19:48:03 • 1 min
A devastating condition which causes the heart to fail can be reversed, scientists have found for the first time. Researchers studied three pensioners who...
Daily Mail 2023-06-08 09:47:37 • 1 min
(RTTNews) - A panel of independent advisors convened by the Food and Drug Administration is currently meeting to determine whether Leqembi, an Alzheimer's...
Nasdaq 2023-06-09 19:05:25 • 1 min
Pharma giant AstraZeneca has signed a huge deal with a UK start-up to create treatments for diabetes and other autoimmune diseases. The FTSE 100 firm will...
Daily Mail 2023-06-09 20:50:08 • 1 min
Results from phase 1/2 EPCORE NHL-2 trial investigating epcoritamab in combination with rituximab-lenalidomide (R2) showed a 98 percent overall response rate...
Benzinga 2023-06-09 07:01:00 • 1 min
POTUS announced intentions to help combat rising flood of discriminatory rules and laws targeting LGBTQ+ communities and protect transgender children AIDS...
The COVID-19 pandemic shined a light on the deep need that people feel for human touch and connection in hospital settings. Having relatives peering through...
The Conversation US 2023-06-09 12:28:20 • 1 min
-Interim results of largest real-world study of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) showed sustained improvement in lung function,...
Benzinga 2023-06-09 15:00:00 • 2 mins
Everything came with a little adventure, said producer Barbara Muschietti.
Fortune 2023-06-08 23:10:20 • 1 min
By Cara Murez HealthDay Reporter THURSDAY, June 8, 2023 (HealthDay News) -- Patients who develop a devastating heart condition have new reason to hope after...
U.S. News & World Report 2023-06-08 10:32:00 • 1 min
-- WU-CART-007 was well-tolerated in patients with R/R T-ALL/LBL, with low incidence of high-grade CRS and immune-related adverse events -- -- WU-CART-007...
Benzinga 2023-06-09 07:00:00 • 2 mins
By Mark Savage BBC Music Correspondent Janelle Mona says her sensuous, hedonistic new album is a riposte to conservatives who want to suppress expressions of...
BBC 2023-06-09 02:32:47 • 1 min
Picture the scene. Chelseas jubilant players are boarding their bus after robbing Bayern Munich of the Champions League in Bavaria when Salomon Kalou, trophy...
The Mirror 2023-06-09 09:00:00 • 2 mins
These recent, new and upcoming books with L.G.B.T.Q. characters offer adventure stories, personal recollections, a riff on a famous novel and more. Pride is...
The New York Times 2023-06-09 14:00:16 • 2 mins
FDA Peripheral and Central Drugs Advisory Committee is meeting Friday (June 9) to discuss a supplemental marketing application for Leqembi (lecanemab)...
WASHINGTON (AP) Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimers drug, a key step toward opening insurance...
U.S. News & World Report 2023-06-09 19:53:01 • 2 mins
Interim Analysis from Phase 2 Trial Demonstrates Compelling Anti-Tumor Activity in Patients with Frontline and Relapsed/Refractory BPDCN; No New Safety...